Glioblastoma: Prognostic factors and predictive response to radio-and chemotherapy

Francesco Fiorica; Maria Colella; Rosaria Taibi; Andrea Bonetti; Jacopo Giuliani; Maria Sole Perrone; Sonia Missiroli; Carlotta Giorgi

doi:10.2174/0929867327666200131095256

Glioblastoma: Prognostic factors and predictive response to radio-and chemotherapy

Francesco Fiorica, Maria Colella, Rosaria Taibi, Andrea Bonetti, Jacopo Giuliani, Maria Sole Perrone, Sonia Missiroli, Carlotta Giorgi

Research output: Contribution to journal › Review article › peer-review

Abstract

Glioblastoma multiforme (GBM) is characterized by poor prognosis despite an aggressive therapeutic strategy. In recent years, many advances have been achieved in the field of glioblastoma biology. Here we try to summarize the main clinical and biological factors impacting clinical prog-nostication and therapy of GBM patients. From that standpoint, hopefully, in the near future, personalized therapies will be available.

Original language	English
Pages (from-to)	2814-2825
Number of pages	12
Journal	Current Medicinal Chemistry
Volume	27
Issue number	17
DOIs	https://doi.org/10.2174/0929867327666200131095256
Publication status	Published - 2020

Keywords

Glioblastoma
Glioblastoma multiforme (GBM)
Predictive response
Prognostic factor

ASJC Scopus subject areas

Biochemistry
Molecular Medicine
Pharmacology
Drug Discovery
Organic Chemistry

Access to Document

10.2174/0929867327666200131095256

Fingerprint Dive into the research topics of 'Glioblastoma: Prognostic factors and predictive response to radio-and chemotherapy'. Together they form a unique fingerprint.

Cite this

Glioblastoma : Prognostic factors and predictive response to radio-and chemotherapy. / Fiorica, Francesco; Colella, Maria; Taibi, Rosaria; Bonetti, Andrea; Giuliani, Jacopo; Perrone, Maria Sole; Missiroli, Sonia; Giorgi, Carlotta.

In: Current Medicinal Chemistry, Vol. 27, No. 17, 2020, p. 2814-2825.

Research output: Contribution to journal › Review article › peer-review

@article{830ba63415844861bac469c21c255f14,

title = "Glioblastoma: Prognostic factors and predictive response to radio-and chemotherapy",

abstract = "Glioblastoma multiforme (GBM) is characterized by poor prognosis despite an aggressive therapeutic strategy. In recent years, many advances have been achieved in the field of glioblastoma biology. Here we try to summarize the main clinical and biological factors impacting clinical prog-nostication and therapy of GBM patients. From that standpoint, hopefully, in the near future, personalized therapies will be available.",

keywords = "Glioblastoma, Glioblastoma multiforme (GBM), Predictive response, Prognostic factor",

author = "Francesco Fiorica and Maria Colella and Rosaria Taibi and Andrea Bonetti and Jacopo Giuliani and Perrone, {Maria Sole} and Sonia Missiroli and Carlotta Giorgi",

year = "2020",

doi = "10.2174/0929867327666200131095256",

language = "English",

volume = "27",

pages = "2814--2825",

journal = "Current Medicinal Chemistry",

issn = "0929-8673",

publisher = "Bentham Science Publishers B.V.",

number = "17",

}

TY - JOUR

T1 - Glioblastoma

T2 - Prognostic factors and predictive response to radio-and chemotherapy

AU - Fiorica, Francesco

AU - Colella, Maria

AU - Taibi, Rosaria

AU - Bonetti, Andrea

AU - Giuliani, Jacopo

AU - Perrone, Maria Sole

AU - Missiroli, Sonia

AU - Giorgi, Carlotta

PY - 2020

Y1 - 2020

N2 - Glioblastoma multiforme (GBM) is characterized by poor prognosis despite an aggressive therapeutic strategy. In recent years, many advances have been achieved in the field of glioblastoma biology. Here we try to summarize the main clinical and biological factors impacting clinical prog-nostication and therapy of GBM patients. From that standpoint, hopefully, in the near future, personalized therapies will be available.

AB - Glioblastoma multiforme (GBM) is characterized by poor prognosis despite an aggressive therapeutic strategy. In recent years, many advances have been achieved in the field of glioblastoma biology. Here we try to summarize the main clinical and biological factors impacting clinical prog-nostication and therapy of GBM patients. From that standpoint, hopefully, in the near future, personalized therapies will be available.

KW - Glioblastoma

KW - Glioblastoma multiforme (GBM)

KW - Predictive response

KW - Prognostic factor

UR - http://www.scopus.com/inward/record.url?scp=85086030412&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85086030412&partnerID=8YFLogxK

U2 - 10.2174/0929867327666200131095256

DO - 10.2174/0929867327666200131095256

M3 - Review article

VL - 27

SP - 2814

EP - 2825

JO - Current Medicinal Chemistry

JF - Current Medicinal Chemistry

SN - 0929-8673

IS - 17

ER -